(Q84757114)
Statements
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial (English)
John A Liu Yin
Michelle A O'Brien
Sarah B Daly
Keith Wheatley